Please login to the form below

Not currently logged in
Email:
Password:

MISSION appoints Paul Wallace as chief business officer

Joins from Medivir where he was executive VP and head of business development

edit-Mission-Paul_WallaceCancer biotech MISSION Therapeutics has named Paul Wallace as chief business officer.

Wallace has worked in business development roles within drug discovery companies for almost 20 years, most recently at Medivir where he was executive VP and head of business development as well as member of the executive management team responsible for strategic and operational leadership, R&D portfolio management and investment planning.

Commenting on his appointment, Wallace said: “I am delighted to be joining the MISSION team at a time when the commercialisation of certain assets is an increasingly promising prospect.

“The diversity of assets created is testimony to the rigour of MISSION's screening platform in this critically important, but hitherto difficult, area of drug discovery.”

During his time at Medivir, he played a key role in the execution of over 25 partnership deals, eight products were taken into clinical development and two drugs were launched.

In his new role, Wallace will construct future business strategy, including the potential of development partnerships.

Anker Lundemose, MISSION CEO, added: “Paul's extensive business development experience will be invaluable in helping us find the right strategic partnerships to fully realise the potential of these assets.

“Our core focus is cancer, but our platform discovery approach has yielded highly promising molecules for other indications, such as Parkinson's disease. We see partnering as an attractive option for taking these non-core projects forward.”

17th March 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics